VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Question for VPT management

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Jul 05, 2023 2:56pm

66 Views

Post# 35527799

RE:Question for VPT management

If it's installed, it's because it will now appear as a sale in the Q3revenues, just like the CEO explained it very clearly in the latest conference call.

But more importantly, it's the validation of this technology that matters the most as it confirms that usefulness of this technology and confirms that there's no other technology that can beat them.fulfill this need. So we'll be bought when enough sales from top-tier are confirmed.

VPT management doesn't manage this SH Board.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario